| Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration PSJ Weston, T Poole, NS Ryan, A Nair, Y Liang, K Macpherson, R Druyeh, ... Neurology 89 (21), 2167-2175, 2017 | 261 | 2017 |
| Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series NS Ryan, JM Nicholas, PSJ Weston, Y Liang, T Lashley, R Guerreiro, ... The Lancet Neurology 15 (13), 1326-1335, 2016 | 221 | 2016 |
| Molecular biomarkers of Alzheimer's disease: progress and prospects T Lashley, JM Schott, P Weston, CE Murray, H Wellington, A Keshavan, ... Disease models & mechanisms 11 (5), dmm031781, 2018 | 212 | 2018 |
| Diffusion imaging changes in grey matter in Alzheimer’s disease: a potential marker of early neurodegeneration PSJ Weston, IJA Simpson, NS Ryan, S Ourselin, NC Fox Alzheimer's research & therapy 7, 1-8, 2015 | 174 | 2015 |
| Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study PSJ Weston, JM Nicholas, SMD Henley, Y Liang, K Macpherson, ... The Lancet Neurology 17 (2), 123-132, 2018 | 112 | 2018 |
| Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic RW Paterson, CF Slattery, T Poole, JM Nicholas, NK Magdalinou, ... Alzheimer's research & therapy 10, 1-11, 2018 | 106 | 2018 |
| Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study A O’Connor, TK Karikari, T Poole, NJ Ashton, J Lantero Rodriguez, ... Molecular psychiatry 26 (10), 5967-5976, 2021 | 93 | 2021 |
| Factors associated with the onset and persistence of post–lumbar puncture headache AE Monserrate, DC Ryman, S Ma, C Xiong, JM Noble, JM Ringman, ... JAMA neurology 72 (3), 325-332, 2015 | 89 | 2015 |
| The use of mini-CEX in UK foundation training six years following its introduction: lessons still to be learned and the benefit of formal teaching regarding its utility PSJ Weston, CA Smith Medical Teacher 36 (2), 155-163, 2014 | 78 | 2014 |
| Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease PSJ Weston, T Poole, A O’Connor, A Heslegrave, NS Ryan, Y Liang, ... Alzheimer's research & therapy 11, 1-7, 2019 | 77 | 2019 |
| Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study PSJ Weston, JM Nicholas, M Lehmann, NS Ryan, Y Liang, K Macpherson, ... Neurology 87 (19), 2050-2057, 2016 | 77 | 2016 |
| Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease DOT Alawode, AJ Heslegrave, NJ Ashton, TK Karikari, J Simrén, ... Journal of internal medicine 290 (3), 583-601, 2021 | 59 | 2021 |
| Direct parametric reconstruction with joint motion estimation/correction for dynamic brain PET data J Jiao, A Bousse, K Thielemans, N Burgos, PSJ Weston, JM Schott, ... IEEE transactions on medical imaging 36 (1), 203-213, 2016 | 39 | 2016 |
| Discrimination of voice gender in the human auditory cortex PSJ Weston, MD Hunter, DS Sokhi, ID Wilkinson, PWR Woodruff NeuroImage 105, 208-214, 2015 | 38 | 2015 |
| Diagnosing dementia in the clinical setting: can amyloid PET provide additional value over cerebrospinal fluid? PSJ Weston, RW Paterson, J Dickson, A Barnes, JB Bomanji, I Kayani, ... Journal of Alzheimer's Disease 54 (4), 1297-1302, 2016 | 25 | 2016 |
| Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer’s disease PSJ Weston, T Poole, JM Nicholas, N Toussaint, IJA Simpson, M Modat, ... Alzheimer's research & therapy 12, 1-10, 2020 | 23 | 2020 |
| Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes PSJ Weston, RW Paterson, M Modat, N Burgos, MJ Cardoso, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (4 …, 2015 | 21 | 2015 |
| Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study A O'Connor, E Abel, AL Benedet, T Poole, N Ashton, PSJ Weston, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 90-92, 2023 | 18 | 2023 |
| Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept CJ Scott, J Jiao, A Melbourne, N Burgos, DM Cash, E De Vita, ... Journal of Cerebral Blood Flow & Metabolism 39 (12), 2419-2432, 2019 | 18 | 2019 |
| Plasma amyloid-β ratios in autosomal dominant Alzheimer’s disease: the influence of genotype A O'Connor, J Pannee, T Poole, C Arber, E Portelius, IJ Swift, ... Brain 144 (10), 2964-2970, 2021 | 17 | 2021 |
